ArticleJournal of clinical medicine2021

Safety and Effectiveness of Vedolizumab for the Treatment of Pediatric Patients with Very Early Onset Inflammatory Bowel Diseases.

Sylwia Fabiszewska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.